Fact Sheet for Healthcare Providers: Elecsys Anti-SARS-CoV-2; Roche Diagnostics

Source: U.S. Food and Drug Administration (FDA). Published: 5/2/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Elecsys Anti- SARS-CoV-2 immunoassay, which received an Emergency Use Authorization from the Food and Drug Administration on May 2, 2020. The Elecsys Anti-SARS-CoV-2 immunoassay is authorized for the detection of antibodies to SARS-CoV-2 in human serum or plasma. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news